| Summary of Operating Segment Expenses |
The following table presents significant expense information about the Company’s operating segment (in thousands):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended June 30, |
|
|
|
Six Months Ended June 30, |
|
|
|
|
2026 |
|
|
2025 |
|
|
2026 |
|
|
2025 |
|
Operating expenses: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Employee related expense(1) |
|
$ |
|
37,445 |
|
|
$ |
|
32,484 |
|
|
$ |
|
74,971 |
|
|
$ |
|
55,422 |
|
External R&D expense - apitegromab |
|
|
|
22,948 |
|
|
|
|
27,956 |
|
|
|
|
43,209 |
|
|
|
|
47,257 |
|
External R&D expense - SRK-181 |
|
|
|
9 |
|
|
|
|
792 |
|
|
|
|
45 |
|
|
|
|
1,902 |
|
External R&D expense - SRK-439 |
|
|
|
3,760 |
|
|
|
|
2,575 |
|
|
|
|
5,519 |
|
|
|
|
6,854 |
|
External R&D expense - Early research and other |
|
|
|
1,610 |
|
|
|
|
2,227 |
|
|
|
|
2,820 |
|
|
|
|
3,682 |
|
External expense - G&A |
|
|
|
16,597 |
|
|
|
|
14,952 |
|
|
|
|
32,729 |
|
|
|
|
23,895 |
|
Other segment items(2) |
|
|
|
6,573 |
|
|
|
|
6,273 |
|
|
|
|
13,082 |
|
|
|
|
11,531 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Equity-based compensation expense |
|
|
|
19,662 |
|
|
|
|
24,433 |
|
|
|
|
37,907 |
|
|
|
|
37,846 |
|
Depreciation and amortization expense |
|
|
|
297 |
|
|
|
|
417 |
|
|
|
|
632 |
|
|
|
|
810 |
|
Loss on disposal of property and equipment |
|
|
|
- |
|
|
|
|
- |
|
|
|
|
3 |
|
|
|
|
- |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Other non-operating expense/(income), net |
|
|
|
995 |
|
|
|
|
(2,078 |
) |
|
|
|
4,489 |
|
|
|
|
(4,445 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net loss |
|
$ |
|
109,896 |
|
|
$ |
|
110,031 |
|
|
$ |
|
215,406 |
|
|
$ |
|
184,754 |
|
(1)Excludes equity-based compensation expense. (2)Consists of other segment expenses related to supplies, corporate and facilities expenses.
|